Guideline Concordance in Nova Scotia

We’re excited to share the first project results from the Breast Health Research Unit (BHRU)!

Our study explores differences in geographic location and the use of neoadjuvant chemotherapy among patients with TNBC and HER2+ breast cancers. These findings will guide future research aimed at improving neoadjuvant guideline concordance and, ultimately, outcomes for breast cancer patients